Bill > S2661

This bill, known as the Hospice Safe Drug Disposal Act of 2018, amends the Controlled Substances Act to allow employees of qualified hospice programs to handle and assist in the disposal of controlled substances that were lawfully dispensed to a hospice patient after the patient's death. The bill requires hospice programs to have written policies and procedures for this purpose and to educate patients and their families on safe disposal practices. Additionally, the bill directs the Attorney General to issue guidance to help hospice programs comply with the new requirements, and it requires the Government Accountability Office (GAO) to study the challenges and federal requirements related to the disposal of controlled substances in a home hospice setting.

Justice

https://www.congress.gov/bill/115th-congress/senate-bill/2661/all-info